Surgery Partners Inc
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers … Read more
Surgery Partners Inc (SGRY) - Net Assets
Latest net assets as of September 2025: $3.55 Billion USD
Based on the latest financial reports, Surgery Partners Inc (SGRY) has net assets worth $3.55 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.95 Billion) and total liabilities ($4.39 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.55 Billion |
| % of Total Assets | 44.71% |
| Annual Growth Rate | N/A |
| 5-Year Change | 123.93% |
| 10-Year Change | N/A |
| Growth Volatility | 47.68 |
Surgery Partners Inc - Net Assets Trend (2013–2024)
This chart illustrates how Surgery Partners Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Surgery Partners Inc (2013–2024)
The table below shows the annual net assets of Surgery Partners Inc from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $3.64 Billion | +8.13% |
| 2023-12-31 | $3.36 Billion | +2.41% |
| 2022-12-31 | $3.28 Billion | +42.75% |
| 2021-12-31 | $2.30 Billion | +41.67% |
| 2020-12-31 | $1.62 Billion | -4.47% |
| 2019-12-31 | $1.70 Billion | -- |
| 2018-12-31 | $0.00 | -- |
| 2017-12-31 | $0.00 | -- |
| 2016-12-31 | $0.00 | -- |
| 2015-12-31 | $0.00 | -- |
| 2014-12-31 | $222.12 Million | +1645.22% |
| 2013-12-31 | $-14.38 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Surgery Partners Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 57396400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.30 Million | 0.07% |
| Other Comprehensive Income | $4.80 Million | 0.27% |
| Other Components | $2.52 Billion | 140.86% |
| Total Equity | $1.79 Billion | 100.00% |
Surgery Partners Inc Competitors by Market Cap
The table below lists competitors of Surgery Partners Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Iperionx Ltd
AU:IPX
|
$703.27 Million |
|
Jilin Liyuan Precision Manufacturing Co Ltd
SHE:002501
|
$703.83 Million |
|
Sparekassen Sjaelland-Fyn A/S
CO:SPKSJF
|
$703.86 Million |
|
Ami Organics Limited
NSE:AMIORG
|
$704.27 Million |
|
Man Wah Holdings Limited
F:AAM
|
$703.07 Million |
|
Fujian Guanfu Modern Household Wares Co Ltd
SHE:002102
|
$702.75 Million |
|
Hosiden Corporation
F:HOD
|
$702.46 Million |
|
Grand City Properties S.A
PINK:GRNNF
|
$702.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Surgery Partners Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,987,200,000 to 1,789,700,000, a change of -197,500,000 (-9.9%).
- Net loss of 168,100,000 reduced equity.
- Other comprehensive income decreased equity by 52,700,000.
- Other factors increased equity by 23,300,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-168.10 Million | -9.39% |
| Other Comprehensive Income | $-52.70 Million | -2.94% |
| Other Changes | $23.30 Million | +1.3% |
| Total Change | $- | -9.94% |
Book Value vs Market Value Analysis
This analysis compares Surgery Partners Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.89x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $-2.15 | $12.65 | x |
| 2014-12-31 | $-5.48 | $12.65 | x |
| 2015-12-31 | $-0.11 | $12.65 | x |
| 2016-12-31 | $0.20 | $12.65 | x |
| 2017-12-31 | $13.36 | $12.65 | x |
| 2018-12-31 | $8.43 | $12.65 | x |
| 2019-12-31 | $14.33 | $12.65 | x |
| 2020-12-31 | $11.28 | $12.65 | x |
| 2021-12-31 | $15.04 | $12.65 | x |
| 2022-12-31 | $21.73 | $12.65 | x |
| 2023-12-31 | $15.82 | $12.65 | x |
| 2024-12-31 | $14.19 | $12.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Surgery Partners Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.39%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.40%
- • Asset Turnover: 0.39x
- • Equity Multiplier: 4.41x
- Recent ROE (-9.39%) is below the historical average (-1.03%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | -3.18% | 0.60x | 0.00x | $1.30 Million |
| 2014 | 0.00% | -16.34% | 0.22x | 0.00x | $-39.49 Million |
| 2015 | 0.00% | 0.15% | 0.46x | 0.00x | $1.83 Million |
| 2016 | 97.69% | 0.83% | 0.50x | 238.19x | $8.49 Million |
| 2017 | -8.09% | -3.95% | 0.29x | 7.06x | $-118.46 Million |
| 2018 | -50.84% | -11.61% | 0.38x | 11.56x | $-246.17 Million |
| 2019 | -10.81% | -4.08% | 0.36x | 7.25x | $-143.98 Million |
| 2020 | -21.11% | -6.24% | 0.34x | 9.84x | $-171.11 Million |
| 2021 | -6.51% | -3.19% | 0.36x | 5.62x | $-179.80 Million |
| 2022 | -2.73% | -2.15% | 0.38x | 3.34x | $-254.42 Million |
| 2023 | -0.60% | -0.43% | 0.40x | 3.46x | $-210.62 Million |
| 2024 | -9.39% | -5.40% | 0.39x | 4.41x | $-347.07 Million |
Industry Comparison
This section compares Surgery Partners Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Surgery Partners Inc (SGRY) | $3.55 Billion | 0.00% | 1.24x | $703.09 Million |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |